PubRank

Risk Markers in the Acute Coronary Syndromes (RACS)

Clinical Trial ID NCT00521976

PubWeight™ 6.53‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00521976

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Atherosclerosis--an inflammatory disease. N Engl J Med 1999 59.28
2 The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994 8.10
3 Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004 7.12
4 The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001 5.50
5 N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002 3.79
6 Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998 2.51
7 B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003 2.22
8 Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995 2.15
9 Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990 2.11
10 Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003 1.89
11 Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004 1.79
12 Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 2006 1.73
13 Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000 1.10
14 Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids 2011 0.97
15 Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vasc Biol 1997 0.95
16 Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 2000 0.91
17 Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 1998 0.89
18 Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome. Circ J 2006 0.87
19 B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. BMC Cardiovasc Disord 2008 0.85
20 The latest and greatest new biomarkers: which ones should we measure for risk prediction in our practice? Arch Intern Med 2006 0.83
21 Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. J Thromb Haemost 2008 0.82
22 Prognostic utility of vitamin D in acute coronary syndrome patients in coastal Norway. Dis Markers 2015 0.81
23 The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thromb Haemost 2009 0.81
24 N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. Am J Med 2006 0.80
25 Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagul Fibrinolysis 2009 0.77
26 Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome. Front Cardiovasc Med 2016 0.75
27 Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not Predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did. Front Cardiovasc Med 2015 0.75
28 Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. Scand Cardiovasc J 2013 0.75
Next 100